Diabetes Canada, Toronto, Canada.
Institute for Clinical Evaluative Sciences, Toronto, Canada.
J Gen Intern Med. 2020 Sep;35(9):2662-2667. doi: 10.1007/s11606-020-05747-9. Epub 2020 Mar 10.
Diabetes Canada launched a comprehensive Dissemination and Implementation (D&I) strategy to optimize uptake of their 2013 Clinical Practice Guidelines; the strategy involved continuing professional development courses, webinars, an interactive website, applications for mobile devices, point-of-care decision support tools, and media awareness campaigns. It included a focus on promoting HbA1c as the recommended diagnostic test for diabetes.
To determine the impact of Diabetes Canada's 2013 D&I strategy on physician test-ordering behavior, specifically HbA1c testing, for the diagnosis of diabetes, using provincial healthcare administrative data.
Population-based interrupted time series.
Ontario, Canada.
Ontario residents aged 40-79 not previously diagnosed with diabetes.
For each quarter between January 2005 and December 2014, we conducted an interrupted time series analysis on the first-order difference of the proportion of patients receiving HbA1c tests per quarter with an autoregressive integrated moving average model with the intervention step occurring in quarter 2 of 2013. Subgroup analyses by rurality, physician graduation year, and practice size were also conducted.
There were 32 quarters pre-intervention and 6 post-intervention; average sample size per quarter was 5,298,686 individuals. Pre-intervention, the quarter-to-quarter growth was 1.51 HbA1c tests per quarter per 1000 people. Post-intervention, the quarter-to-quarter growth increased by 8.45 tests per 1000 people (p < 0.005). Growth of HbA1c ordering differed significantly by region, years since physician graduation, and practice size.
Incomplete data collection, inadequate stratification, and other unidentified confounders.
The D&I strategy resulted in a significant increase in the growth of HbA1c tests. The successful uptake of this recommendation may be due to its simplicity; guideline developers should consider this when drafting recommendations. Furthermore, differential uptake by user groups suggests that future strategies should include targeted barrier analysis and interventions to these groups.
加拿大糖尿病协会推出了一项全面的传播和实施(D&I)策略,以优化其 2013 年临床实践指南的应用;该策略包括继续教育课程、网络研讨会、互动网站、移动设备应用程序、即时护理决策支持工具和媒体宣传活动。该策略还特别强调将糖化血红蛋白(HbA1c)作为诊断糖尿病的推荐检测方法。
利用安大略省的医疗保健管理数据,确定加拿大糖尿病协会 2013 年 D&I 策略对医生检测开单行为(特别是 HbA1c 检测)的影响,以诊断糖尿病。
基于人群的中断时间序列研究。
加拿大安大略省。
年龄在 40-79 岁之间、之前未被诊断患有糖尿病的安大略省居民。
对于 2005 年 1 月至 2014 年 12 月的每个季度,我们使用自回归积分移动平均模型对每季度接受 HbA1c 检测的患者比例进行一阶差分的中断时间序列分析,干预步骤发生在 2013 年第 2 季度。还进行了农村地区、医生毕业年份和实践规模的亚组分析。
干预前有 32 个季度,干预后有 6 个季度;每个季度的平均样本量为 5298686 人。在干预前,每季度每 1000 人 HbA1c 检测量的季度增长率为 1.51 次。在干预后,每季度每 1000 人 HbA1c 检测量的季度增长率增加了 8.45 次(p<0.005)。HbA1c 检测量的增长在区域、医生毕业后年限和实践规模方面有显著差异。
数据收集不完整,分层不足和其他未识别的混杂因素。
D&I 策略导致 HbA1c 检测量的显著增长。该建议的成功采用可能归因于其简单性;指南制定者在起草建议时应考虑到这一点。此外,不同用户群体的采用情况表明,未来的策略应包括针对这些群体的目标障碍分析和干预措施。